Trulieve Cannabis TRLV 深 沪
已收盘 08-21 16:00:00 美东时间
11.10
+0.850
+8.29%
华盛通- 最 高11.17
- 今 开10.30
- 成交量 161.31万股
- 最 低 10.24
- 昨 收 10.25
- 总市值 21.37亿
- 52周最高 12.30
- 市盈率 静 --
- 换手率 0.84%
- 52周最低 7.82
- 委 比 25.00%
- 总股本 1.93亿
- 历史最高 12.30
- 量 比 1.55
- 振 幅 9.07%
- 历史最低 7.82
- 每 手 1
- 风险率 0.80%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Trulieve Completes Redomicile from British Columbia to Delaware
TALLAHASSEE, Fla., Aug. 11, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today ...
08-12 04:10
美股大行评级 | 花旗下调美光科技目标价从1400美元降至1150美元；爱彼迎、Datadog、Cloudflare、Etsy、Natera、拉夫劳伦获多家大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持InflaRx"超配"评级，目标价从4美元升至6美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从19美元升至20美元
08-10 19:24
Cantor Fitzgerald Reiterates Overweight on Trulieve Cannabis, Maintains $15 Price Target
Cantor Fitzgerald analyst Gabie Ingoglia reiterates Trulieve Cannabis (NYSE:TRLV) with a Overweight and maintains $15 price target.
08-08 02:03
Trulieve Cannabis Q2 Adj. EPS $0.11 Beats $0.06 Estimate, Sales $271.000M Beat $268.494M Estimate
Trulieve Cannabis (NYSE:TRLV) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.06 by 83.33 percent. This is a 375 percent increase over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $271.000 million w...
08-07 21:04
Trulieve Announces August 2026 Event Participation
TALLAHASSEE, Fla., Aug. 5, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S, today an...
08-05 20:00
美股大行评级 | 伯恩斯坦上调Robinhood目标价从130美元升至160美元；纽约梅隆银行、Datadog、五三银行、旅行者财产险集团获多家机构上调评级
今日重点评级关注：Needham：维持Immuneering"买入"评级，目标价从11美元升至18美元；富瑞：维持塞德斯医疗"买入"评级，目标价从90美元升至100美元
07-21 11:36
Cantor Fitzgerald Initiates Coverage On Trulieve Cannabis with Overweight Rating, Announces Price Target of $15
Cantor Fitzgerald analyst Gabie Ingoglia initiates coverage on Trulieve Cannabis (NYSE:TRLV) with a Overweight rating and announces Price Target of $15.
07-20 19:25
Trulieve Cannabis CEO To Terminate 10b5-1 Share Sale Plan After Completing First Tranche Of 2.5M Share Disposition
Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced that Ms. Kim Rivers, the Company's Chairman and Chief Executive Officer, has notified the broker dealer administering her automatic securities disposition pl...
06-27 04:31
Jim Cramer Calls CAVA 'Tasty, Clean, Fun,' Says Make This Biotech 'Your Speculation'
On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying CAVA Group, Inc. (NYSE:CAVA). “I think it's the best of the new concepts. I think there's something there for everybody. There really is. It's tasty, clean, fun,” he added. Supporting his view, UBS analyst Dennis Geiger, on June 10...
06-17 19:50
